| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |